1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with dantrolene in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (dantrolene) | Trials (dantrolene) | Recent Studies (post-2010) (dantrolene) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 2,005 | 55 | 359 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Haskó, G; Lendvai, B; Sántha, E; Szelényi, J | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and dantrolene
Article | Year |
---|---|
Platelet-activating factor evokes Ca2+ transients after the blockade of ryanodine receptor by dantrolene in RAW 264.7 macrophages.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Dantrolene; Macrophages; Mice; Platelet Activating Factor; Ryanodine Receptor Calcium Release Channel | 2001 |